Conquering Cancer Close to Home
Request Appointment
Providers Locations Conditions We Treat Clinical Trials About Us Careers

Dr. Richard Zuniga

Medical Oncology & Hematology

Richard Zuniga, MD is a board-certified hematologist and oncologist. Dr. Richard Zuniga practiced as an attending physician and then became the Medical Director of Clinical Research at Lowell General Cancer Center. Previously, he practiced at New York Methodist Hospital, where he received the Attending Teaching Excellence Award in 2015.

Before practicing medicine, Dr. Zuniga earned his Medical Degree at Universidad de San Martin de Porres in Peru. Dr. Zuniga completed his residency, and his first fellowship at Henry Ford Hospital, where he also practiced as an Attending Physician.

He then completed two more fellowships; in hematology/oncology, and Drug Development Research at the University of Texas Health Science Center.

Dr. Zuniga has been recognized for his fight against breast cancer, receiving the Breast Cancer Achievement Award from the Lynn Sage Breast Cancer Symposium in 2010. He is a member of the American Society of Clinical Oncology and Hematology, The European Society of Hematology, and the Society for Neuro-Oncology.

He has authored several peer-reviewed manuscripts, which have been featured in the Journal of Neuro-Oncology. He holds an appointment as an Adjunct Assistant Clinical Professorship at Mount Sinai.

Professional Background

Specialization

Medical Oncology & Hematology

Years in Practice

19+

Languages

English, Spanish, French

Medical School

Universidad de San Martin de Porres

Residency

Henry Ford Hospital

Fellowship

University of Texas Health Service Center, Clinical Research Henry Ford Hospital

Hospital Affiliations

  • • Good Samaritan Medical Center
  • • Long Island Community Hospital
  • • Southside Hospital

Ask Your Patient Navigator

Get instant answers about doctors, locations, and services

This AI powered Patient Navigator provides general information only and does not offer medical advice. By using this tool, you agree to our Terms of Use and Privacy Policy.

Clear